Trials / Completed
CompletedNCT01624012
Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist Versus Nasal Continuous Airway Pressure in Premature Infants
Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist (NIV NAVA) Versus Nasal Continuous Airway Pressure (NCPAP) in Premature Infants
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Oulu · Academic / Other
- Sex
- All
- Age
- 1 Hour – 48 Hours
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare if a new noninvasive ventilation mode (NIV NAVA) is better in noninvasive ventilation of premature infants than currently used Nasal Continuous Airway Pressure (ncpap), and if NIV NAVA gives real benefits for patients or not. The investigators study hypothesis is that with NIV NAVA the invasive ventilation is more synchronous with patient, which will lead to a decrease in need of inspired oxygen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NIV NAVA | Non invasive ventilation with neurally adjusted ventilatory assist |
| DEVICE | Nasal continuous positive airway pressure | Noninvasive respiratory support with continuous positive airway pressure |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2015-08-01
- Completion
- 2016-05-01
- First posted
- 2012-06-20
- Last updated
- 2016-05-12
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01624012. Inclusion in this directory is not an endorsement.